Lluch, Ana <br/><br/>
Emerging EGFR antagonists for breast cancer.  [electronic resource] 

 -  Expert opinion on emerging drugs  Jun 2014 
 - 165-81 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-7623 
<br/><br/><label>Standard No.: </label>10.1517/14728214.2014.903919  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Cetuximab<br/>Drug Discovery<br/>Epithelial-Mesenchymal Transition<br/>ErbB Receptors--antagonists & inhibitors<br/>Female<br/>Gefitinib<br/>Humans<br/>Panitumumab<br/>Protein Kinase Inhibitors--therapeutic use<br/>Quinazolines--therapeutic use